Free shipping on all orders over $ 500

 About 1 result found for searched term "1446700-26-0" (0.123 seconds)

Cat.No.  Name Target
M14134 Rociletinib hydrobromide EGFR/HER2
CO-1686 hydrobromide; AVL-301 hydrobromide; CNX-419 hydrobromide
Rociletinib hydrobromide (CO-1686 hydrobromide) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.